Cargando…
Viral proteases as therapeutic targets
Some medically important viruses―including retroviruses, flaviviruses, coronaviruses, and herpesviruses―code for a protease, which is indispensable for viral maturation and pathogenesis. Viral protease inhibitors have become an important class of antiviral drugs. Development of the first-in-class vi...
Autores principales: | Majerová, Taťána, Konvalinka, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706241/ https://www.ncbi.nlm.nih.gov/pubmed/36459838 http://dx.doi.org/10.1016/j.mam.2022.101159 |
Ejemplares similares
-
Precursors of Viral Proteases as Distinct Drug Targets
por: Majerová, Taťána, et al.
Publicado: (2021) -
Inhibition of the precursor and mature forms of HIV-1 protease as a tool for drug evaluation
por: Humpolíčková, Jana, et al.
Publicado: (2018) -
Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009) -
The Nuclear Pore Complex Is a Key Target of Viral Proteases to Promote Viral Replication
por: De Jesús-González, Luis Adrián, et al.
Publicado: (2021) -
Viral proteases as targets for chemotherapeutic intervention
por: Hellen, Christopher U.T., et al.
Publicado: (1992)